XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.2
LICENSE AGREEMENTS (Details)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2012
USD ($)
Jun. 30, 2022
USD ($)
item
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
item
Jun. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Revenue   $ 594,000 $ 1,545,000 $ 2,610,000 $ 2,338,000  
TG-1101 [Member]            
Upfront fee $ 2,000,000.0     2,000,000   $ 2,000,000
Income taxes $ 300,000          
Revenue   38,000 $ 38,000 76,000 $ 76,000  
Term after first commercial sale 15 years          
Deferred Revenue   500,000   500,000   600,000
Deferred Revenue, Current   200,000   200,000   200,000
TG-1101 [Member] | Maximum [Member]            
Potential milestones payable   5,000,000.0   5,000,000.0    
TGR-1202 [Member]            
Expenses incurred       24,000,000.0    
Additional payments on achievement of certain milestones   $ 150,000,000.0   $ 150,000,000.0    
Number of oncology indications | item   2   2    
Number of non oncology indications | item   1   1    
Royalty Expense       $ 200,000    
Royalty payable   $ 100,000   100,000   $ 200,000
LFB License Agreement            
Additional payments on achievement of certain milestones   13,000,000.0   $ 13,000,000.0    
LFB Group [Member]            
Term after first commercial sale       15 years    
Additional payments on achievement of certain milestones   $ 18,000,000.0   $ 18,000,000.0